Including Everyone in Clinical Trials for Myelodysplastic Syndromes (MDS) скачать в хорошем качестве

Including Everyone in Clinical Trials for Myelodysplastic Syndromes (MDS)

Learn more about MDS at http://www.YouAndMDS.com This animation provides an overview of the importance of including everyone in clinical trials for myelodysplastic syndromes (MDS). Researchers are working hard on new ways to screen for, diagnose, and treat MDS for everyone. However, only 6 in every 100 people with all types of cancer volunteer for a clinical trial. Some research suggests that people of different ethnicities may tend to develop different types of MDS. This can affect diagnosis and treatment for people from each group. Therefore to know what is most effective, MDS clinical trials need diverse participants and it is important for all groups to take part in clinical trials. Watch through to learn about how clinical trials can offer everyone with MDS the chance to try treatments that are not yet available to the public. Be sure to ask your doctor about how taking part in an MDS clinical trial can help you and help researchers learn about safety and effectiveness of new MDS treatments and improve care for everyone.